Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fumiko Suzuki

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Human Vaccines & Immunotherapeutics|March 10, 2015
CpG oligodeoxynucleotides as mucosal adjuvantsSumiko Iho, Jun-ichi Maeyama, Fumiko Suzuki
Genes to Cells : Devoted to Molecular & Cellular Mechanisms|September 26, 2020
Overexpression of neural miRNAs miR-9/9* and miR-124 suppresses differentiation to Müller glia and promotes differentiation to neurons in mouse retina in vivoFumiko Suzuki, Mariko Okuno, Tomoya Tanaka, et al.
Respiratory Investigation|January 1, 2016
Hyperoxia causes diffuse alveolar damage through mechanisms involving upregulation of c-Myc/Bax and enhanced production of reactive oxygen speciesIchiroh Shimada, Ayumi Kubota, Masataka Katoh, et al.
British Journal of Pharmacology|January 14, 2004
Alpha-1 adrenoceptors: evaluation of receptor subtype-binding kinetics in intact arterial tissues and comparison with membrane bindingTakashi Tanaka, Li Zhang, Fumiko Suzuki, et al.
The Journal of Biological Chemistry|August 9, 2007
Snapin, a new regulator of receptor signaling, augments alpha1A-adrenoceptor-operated calcium influx through TRPC6Fumiko Suzuki, Shigeru Morishima, Takashi Tanaka, et al.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|March 7, 2006
[Alpha1-adrenoceptor subtypes and alpha1-adrenoceptor antagonists]Ikunobu Muramatsu, Fumiko Suzuki, Takashi Tanaka, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 15, 2004
Pharmacological characterization and cross talk of alpha1a- and alpha1b-adrenoceptors coexpressed in human embryonic kidney 293 cellsMalika Israilova, Takashi Tanaka, Fumiko Suzuki, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|August 22, 2009
Alpha 1-adrenoceptor pharmacome: alpha 1L-adrenoceptor and alpha 1A-adrenoceptor in the lower urinary tractAtsushi Nishimune, Fumiko Suzuki, Hatsumi Yoshiki, et al.
Journal of Pharmacological Sciences|May 29, 2010
Identification of cysteine-rich epidermal growth factor-like domain 1alpha (CRELD1alpha) as a novel alpha1A-adrenoceptor-down-regulating protein and establishment of an alpha1L-adrenoceptor-expressing cell lineAtsushi Nishimune, Fumiko Suzuki, Hatsumi Yoshiki, et al.
Brain, Behavior, and Immunity|April 16, 2019
Normal aging hyperactivates innate immunity and reduces the medical efficacy of minocycline in brain injuryRikako Sanuki, Tomoya Tanaka, Fumiko Suzuki, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Human Vaccines & Immunotherapeutics|March 10, 2015
CpG oligodeoxynucleotides as mucosal adjuvantsSumiko Iho, Jun-ichi Maeyama, Fumiko Suzuki
Genes to Cells : Devoted to Molecular & Cellular Mechanisms|September 26, 2020
Overexpression of neural miRNAs miR-9/9* and miR-124 suppresses differentiation to Müller glia and promotes differentiation to neurons in mouse retina in vivoFumiko Suzuki, Mariko Okuno, Tomoya Tanaka, et al.
Respiratory Investigation|January 1, 2016
Hyperoxia causes diffuse alveolar damage through mechanisms involving upregulation of c-Myc/Bax and enhanced production of reactive oxygen speciesIchiroh Shimada, Ayumi Kubota, Masataka Katoh, et al.
British Journal of Pharmacology|January 14, 2004
Alpha-1 adrenoceptors: evaluation of receptor subtype-binding kinetics in intact arterial tissues and comparison with membrane bindingTakashi Tanaka, Li Zhang, Fumiko Suzuki, et al.
The Journal of Biological Chemistry|August 9, 2007
Snapin, a new regulator of receptor signaling, augments alpha1A-adrenoceptor-operated calcium influx through TRPC6Fumiko Suzuki, Shigeru Morishima, Takashi Tanaka, et al.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|March 7, 2006
[Alpha1-adrenoceptor subtypes and alpha1-adrenoceptor antagonists]Ikunobu Muramatsu, Fumiko Suzuki, Takashi Tanaka, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 15, 2004
Pharmacological characterization and cross talk of alpha1a- and alpha1b-adrenoceptors coexpressed in human embryonic kidney 293 cellsMalika Israilova, Takashi Tanaka, Fumiko Suzuki, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|August 22, 2009
Alpha 1-adrenoceptor pharmacome: alpha 1L-adrenoceptor and alpha 1A-adrenoceptor in the lower urinary tractAtsushi Nishimune, Fumiko Suzuki, Hatsumi Yoshiki, et al.
Journal of Pharmacological Sciences|May 29, 2010
Identification of cysteine-rich epidermal growth factor-like domain 1alpha (CRELD1alpha) as a novel alpha1A-adrenoceptor-down-regulating protein and establishment of an alpha1L-adrenoceptor-expressing cell lineAtsushi Nishimune, Fumiko Suzuki, Hatsumi Yoshiki, et al.
Brain, Behavior, and Immunity|April 16, 2019
Normal aging hyperactivates innate immunity and reduces the medical efficacy of minocycline in brain injuryRikako Sanuki, Tomoya Tanaka, Fumiko Suzuki, et al.
Pageof 4